Laboratorios Farmaceuticos Rovi (ROVI)

Index:

IBEX 35

  64.05
   
  • 52 Week High:  79.90
  • 52 Week Low:  42.40
  • Currency: Euro
  • Shares Issued: 51.21m
  • Market Cap:  3,280.00m
  • RiskGrade: 165
  • Beta: 0.51

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 459.42 75.22 110.00¢ n/a n/a +57% 17.51¢ 0.0%
31-Dec-21 648.68 182.63 276.00¢ 26.7 0.2 +151% 38.12¢ 0.5%
31-Dec-22 817.70 257.97 373.00¢ 9.7 0.3 +35% 95.56¢ 2.7%
31-Dec-23 829.51 220.41 320.00¢ 18.8 n/a -14% 129.38¢ 2.1%
31-Dec-24 763.75 177.69 267.00¢ 23.6 n/a -17% 94.00¢ 1.5%

Forecasts

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 728.23 164.96 246.37¢ 26.0 n/a -8% 94.00¢ 0.0%
31-Dec-26 832.66 212.26 319.62¢ 20.0 0.7 +30% 109.38¢ 0.0%
31-Dec-27 940.00 273.32 417.50¢ 15.3 0.5 +31% 146.67¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 26.74 9.67 n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

ROVI Market Data

Currency Euro
% Change 6.31 %
52 Week High  79.90
52 Week Low  42.40
Shares Issued 51.21m
Market Cap  3,280.00m
Beta 0.51
RiskGrade 165

What The Brokers Say

Strong Buy 2
Buy 5
Neutral 2
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page